Fundraising FoxVaccinogen
Baltimore, US · Maryland corporation
Find your way into Vaccinogen
Sign up to see every warm intro you have to Vaccinogen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Vaccinogen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MG
Michael G. Hanna, Jr.FounderMichael G. Hanna, Jr. holds a Ph.D. in experimental pathology and immunology from the University of Tennessee and has spent four decades in immunology and vaccine development, including roles as Director of the National Cancer Institute's Frederick Cancer Research Center, Chief Operating Officer of Organon Teknika/Biotechnology Research Institute, and founder of PerImmune Inc. and Vaccinogen Inc., which he currently chairs as Chairman Emeritus while developing OncoVAX, a cancer vaccine in Phase 3 trials.
HE
Hakan EdstromExecutive
Board
AH
Anders HalldinBoard director
RK
Ronald KaiserBoard director
AC
Alan CohenBoard director
JN
John NicolisBoard director
DF
Daniel FitzgeraldBoard director
DK
Daniel KaneBoard director
Reported raises · per SEC filings
Form D private placements$7.2M disclosed across 2 of 4 rounds · 2012–2015
▶$600KraisedNov 2015 · 4 investors · BiotechnologyRule 506(b)
▶$600KraisedNov 2015 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael HagermanDirector
- Hakan EdstromDirector
- Anders HalldinDirector
- Michael G. Hanna, Jr.Director
- Andrew L. TussingExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $600K
- First sale
- Oct 2015
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2015 · 7 investors · BiotechnologyRule 506(b)
▶Undisclosed amountofferedAug 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anders HalldinDirector
- Ronald KaiserDirector
- Hakan EdstromDirector
- Michael G. Hanna, Jr.Director
- Andrew L. TussingExecutive Officer, Director
- First sale
- Apr 2015
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
▶Undisclosed amountofferedAug 2015 · BiotechnologyRule 506(b)
▶Undisclosed amountofferedAug 2015 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael G. Hanna, Jr.Director
- Anders HalldinDirector
- Andrew L. TussingExecutive Officer, Director
- Ronald KaiserDirector
- Hakan EdstromDirector
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
▶$6.6MraisedJan 2014 · 68 investors · BiotechnologyRule 506(b)
▶$6.6MraisedJan 2014 · 68 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alan CohenDirector
- Andrew L. TussingExecutive Officer
- Michael G. Hanna, Jr.Executive Officer, Director
- John NicolisDirector
- Daniel FitzgeraldDirector
- Daniel KaneDirector
- Offering amount
- $13M
- Amount sold
- $6.6M
- Sales commissions
- $14.5K
- Proceeds to insiders
- $339.8K
- Placement agents
- VANGUARD CAPITAL, VANGUARD CAPITAL
- First sale
- Oct 2012
- Incorporated
- Corporation, Maryland
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Vaccinogen?
- Vaccinogen was founded by Michael G. Hanna, Jr..
- How much funding has Vaccinogen raised?
- Vaccinogen has disclosed $7.2M raised across 2 of its 4 known rounds.
- Where is Vaccinogen headquartered?
- Vaccinogen is headquartered in Baltimore, US.